NM_000081.4:c.10564+43G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000081.4(LYST):​c.10564+43G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.482 in 1,571,076 control chromosomes in the GnomAD database, including 195,556 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.53 ( 23488 hom., cov: 32)
Exomes 𝑓: 0.48 ( 172068 hom. )

Consequence

LYST
NM_000081.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.88

Publications

7 publications found
Variant links:
Genes affected
LYST (HGNC:1968): (lysosomal trafficking regulator) This gene encodes a protein that regulates intracellular protein trafficking in endosomes, and may be involved in pigmentation. Mutations in this gene are associated with Chediak-Higashi syndrome, a lysosomal storage disorder. Alternative splicing results in multiple transcript variants, though the full-length nature of some of these variants has not been determined. [provided by RefSeq, Apr 2013]
LYST Gene-Disease associations (from GenCC):
  • Chediak-Higashi syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • attenuated Chédiak-Higashi syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 1-235697040-C-T is Benign according to our data. Variant chr1-235697040-C-T is described in ClinVar as Benign. ClinVar VariationId is 254908.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.715 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LYSTNM_000081.4 linkc.10564+43G>A intron_variant Intron 46 of 52 ENST00000389793.7 NP_000072.2 Q99698-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LYSTENST00000389793.7 linkc.10564+43G>A intron_variant Intron 46 of 52 5 NM_000081.4 ENSP00000374443.2 Q99698-1

Frequencies

GnomAD3 genomes
AF:
0.532
AC:
80881
AN:
152004
Hom.:
23439
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.721
Gnomad AMI
AF:
0.482
Gnomad AMR
AF:
0.381
Gnomad ASJ
AF:
0.489
Gnomad EAS
AF:
0.0451
Gnomad SAS
AF:
0.172
Gnomad FIN
AF:
0.534
Gnomad MID
AF:
0.478
Gnomad NFE
AF:
0.517
Gnomad OTH
AF:
0.509
GnomAD2 exomes
AF:
0.420
AC:
103367
AN:
245900
AF XY:
0.412
show subpopulations
Gnomad AFR exome
AF:
0.731
Gnomad AMR exome
AF:
0.273
Gnomad ASJ exome
AF:
0.492
Gnomad EAS exome
AF:
0.0498
Gnomad FIN exome
AF:
0.535
Gnomad NFE exome
AF:
0.515
Gnomad OTH exome
AF:
0.459
GnomAD4 exome
AF:
0.477
AC:
676800
AN:
1418954
Hom.:
172068
Cov.:
23
AF XY:
0.468
AC XY:
331761
AN XY:
708282
show subpopulations
African (AFR)
AF:
0.726
AC:
23728
AN:
32692
American (AMR)
AF:
0.286
AC:
12676
AN:
44272
Ashkenazi Jewish (ASJ)
AF:
0.495
AC:
12778
AN:
25826
East Asian (EAS)
AF:
0.0509
AC:
2006
AN:
39422
South Asian (SAS)
AF:
0.189
AC:
16037
AN:
84886
European-Finnish (FIN)
AF:
0.540
AC:
28758
AN:
53240
Middle Eastern (MID)
AF:
0.456
AC:
2574
AN:
5646
European-Non Finnish (NFE)
AF:
0.513
AC:
550912
AN:
1074010
Other (OTH)
AF:
0.464
AC:
27331
AN:
58960
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
16618
33236
49853
66471
83089
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15352
30704
46056
61408
76760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.532
AC:
80978
AN:
152122
Hom.:
23488
Cov.:
32
AF XY:
0.519
AC XY:
38594
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.722
AC:
29967
AN:
41498
American (AMR)
AF:
0.381
AC:
5814
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.489
AC:
1696
AN:
3470
East Asian (EAS)
AF:
0.0452
AC:
234
AN:
5180
South Asian (SAS)
AF:
0.171
AC:
823
AN:
4822
European-Finnish (FIN)
AF:
0.534
AC:
5655
AN:
10580
Middle Eastern (MID)
AF:
0.483
AC:
142
AN:
294
European-Non Finnish (NFE)
AF:
0.517
AC:
35139
AN:
67976
Other (OTH)
AF:
0.506
AC:
1068
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1813
3626
5438
7251
9064
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
664
1328
1992
2656
3320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.523
Hom.:
4490
Bravo
AF:
0.532
Asia WGS
AF:
0.161
AC:
563
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Nov 12, 2023
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 43% of patients studied by a panel of primary immunodeficiencies. Number of patients: 41. Only high quality variants are reported. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 19, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.055
DANN
Benign
0.79
PhyloP100
-1.9
Mutation Taster
=24/76
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7541057; hg19: chr1-235860340; API